Impairment of myocardial functions and arterial stiffness in patients with lichen planus

Leyla Baykal Selcuk1, Mursel Sahin1, Deniz Aksu Arıca1

  • 1Department of Dermatology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey.

Insights

Patients with lichen planus, especially erosive lichen planus, show increased arterial stiffness and impaired heart function. Long-term disease duration correlates with higher arterial stiffness, necessitating cardiovascular risk monitoring.

Area of Science:

  • Cardiology
  • Dermatology
  • Vascular Medicine

Background:

  • Lichen planus is a chronic inflammatory disease affecting skin and mucous membranes.
  • Emerging evidence links lichen planus to a higher risk of cardiovascular comorbidities.

Purpose of the Study:

  • To evaluate and compare arterial stiffness and cardiovascular hemodynamics in lichen planus patients versus healthy controls.
  • To investigate the relationship between disease duration and arterial stiffness in lichen planus.

Main Methods:

  • Fifty-five lichen planus patients and 42 healthy controls were recruited.
  • Echocardiography and applanation tonometry were used to assess cardiac function and arterial stiffness.

Main Results:

  • Arterial stiffness was significantly higher in patients with erosive lichen planus compared to controls and non-erosive patients.
  • A moderate positive correlation was found between disease duration and arterial stiffness.
  • Lichen planus patients exhibited impaired systolic and diastolic cardiac functions.

Conclusions:

  • The study highlights potential cardiovascular risks associated with lichen planus, particularly erosive forms.
  • Long-term disease duration and erosive lichen planus warrant closer cardiovascular monitoring.
  • Further research with larger cohorts is needed to confirm these findings.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
272
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
238
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
684
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
186
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
792
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
386